With more than 29 years of experience in the pharmaceutical industry, Mr. Lim was instrumental in establishing the Hyphens Group with the acquisition, from Pan-Malayan Pharmaceuticals Pte Ltd, of the business of wholesale supply of pharmaceutical products and medical supplies in Singapore in 1998, Hyphens Singapore between 2001 and 2004 and Ocean Health Singapore, DAC Pharmalab and Ocean Health Malaysia in 2016, having seen the growth and synergistic opportunities in each of these acquisitions. Headquartered in Singapore, Hyphens is recognised as a leading specialty pharmaceutical and consumer healthcare group. Mr. Lim See Wah was appointed on board of Hyphens as Chairman & CEO on 12th Dec 2017 and is currently responsible for overseeing the overall operations and managing the strategic direction of Hyphens Group. He graduated with a Bachelor of Science (Pharmacy) with Honours (Second Class Honours Upper Division) from the National University of Singapore in June 1992. He obtained a Graduate Diploma in Business Administration from Singapore Institute of Management in May 1994. He also took part in the UC Berkeley-Nanyang Advanced Management Program and the Spring Singapore: Executive Leadership Development Programme at The Wharton School of the University of Pennsylvania in August 2017.